Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FRESENIUS SE : Jefferies reaffirms its Sell rating

02/23/2021 | 03:50am EST

Jefferies is negative on the stock with a Sell rating. The target price remains set at EUR 33.


© MarketScreener with dpa-AFX Analyser 2021
All news about FRESENIUS SE & CO. KGAA
02/24FRESENIUS : wins tenth consecutive Potentialpark award for Germany's best online..
PU
02/24FRESENIUS SE : NorldLB keeps its Buy rating
MD
02/24FRESENIUS MEDICAL CARE : RBC Adjusts Price Target on Fresenius Medical Care to $..
MT
02/24FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reiterates its Neutral rati..
MD
02/24FRESENIUS SE : UBS reiterates its Neutral rating
MD
02/24FMC FRESENIUS MEDICAL CARE AG & CO K : UBS reaffirms its Buy rating
MD
02/24FRESENIUS SE : Independant Research reaffirms its Buy rating
MD
02/24FRESENIUS SE : Credit Suisse sticks Neutral
MD
02/24PRESS RELEASE : Fresenius Medical Care AG & Co. KGaA published form 20-F for the..
DJ
02/23EUROPE : European shares end lower on tech losses as bond yields weigh
RE
More news
Financials
Sales 2020 36 158 M 44 027 M 44 027 M
Net income 2020 1 735 M 2 113 M 2 113 M
Net Debt 2020 23 519 M 28 638 M 28 638 M
P/E ratio 2020 11,2x
Yield 2020 2,27%
Capitalization 19 751 M 23 964 M 24 050 M
EV / Sales 2020 1,20x
EV / Sales 2021 1,15x
Nbr of Employees 309 114
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 45,59 €
Last Close Price 35,43 €
Spread / Highest target 91,9%
Spread / Average Target 28,7%
Spread / Lowest Target -50,1%
EPS Revisions
Managers and Directors
NameTitle
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Gerd Krick Chairman-Supervisory Board
Jürgen Götz Chief Legal & Compliance Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Sector and Competitors